Latest filing published 20 Aug 2026 for Cytek Biosciences, Inc..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
William D. McCombe is a declared insider at 2 companies (finance chief); the most frequent names are Cytek Biosciences, Inc. and Velo3D, Inc. The record holds 34 filings, for trades running from 16 May 2022 to 18 August 2026.
In open-market terms, that means 1 purchase worth €85k on one side and 4 sales worth €85k on the other. Sales outweigh purchases by €369. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 11 share grants and 18 option exercises.
The record was last updated on 20 August 2026 with an option exercise in Cytek Biosciences, Inc. The latest purchase dates back some time: it was published 507 days ago, on 3 June 2025. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations